Suchergebnisse - "LI CHUNLEI"

PubPharm (540)

61

USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME

enthalten in: Europäisches Patentamt | 2023

von LI CHUNLEI | LIU YANPING | WANG CAIXIA | +5

62

USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME

enthalten in: Europäisches Patentamt | 2023

von LI CHUNLEI | LIU YANPING | WANG CAIXIA | +5

63

USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE

enthalten in: Europäisches Patentamt | 2023

von LI CHUNLEI | XIA XUEFANG | LI YANHUI | +5

64

Study on taste quality formation and leaf conducting tissue changes in six types of tea during their manufacturing processes

enthalten in: Food chemistry: X | 2023

von Li, Y. | Yu, S. | Yang, S. | +6

65

Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE) : a randomised, double-blind, double-dummy, active control, non-inferiority trial

enthalten in: The Lancet. Neurology | 2023

von Pan, Y. | Meng, X. | Yuan, B. | +128

CommentIn: Lancet Neurol. 2023 Jun;22(6):457-459. - PMID 37121238

66

Application of mitoxantrone hydrochloride liposome and pepaginase

enthalten in: Europäisches Patentamt | 2023

von LI CHUNLEI | YAN SHUJIE | LI YANHUI | +5

67

COMBINATION OF DOCETAXEL ALBUMIN COMPOSITION AND VEGF INHIBITOR OR VEGFR INHIBITOR AND USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von LI CHUNLEI | ZHANG XIAOJUN | YAO XUEKUN | +7

68

Combination of docetaxel albumin composition and VEGF inhibitor or VEGFR inhibitor and application thereof

enthalten in: Europäisches Patentamt | 2023

von LI CHUNLEI | ZHANG XIAOJUN | YAO XUEKUN | +7

69

Introduction of Surface Modifiers on the Pt-Based Electrocatalysts to Promote the Oxygen Reduction Reaction Process

enthalten in: Nanomaterials (Basel, Switzerland) | 2023

von Wang, H. | Wang, Y. | Li, C. | +2

70

미토산트론 염산염 리포솜 및 시클로포스파미드, 빈크리스틴, 프레드니손의 용도

enthalten in: Europäisches Patentamt | 2023

von LI CHUNLEI | XIA XUEFANG | LI YANHUI | +5